SavedAdd your journal

Journals / International Journal of Traditional and Complementary Medicine Research / 2026 / Volume: 7 Issue: 2

One-Year Outcomes of Bioresonance Therapy for Smoking Cessation: A Prospective Primary Care Study

Gamze Dur(AFYONKARAHISAR HEALTH SCIENCES UNIVERSITY)0000-0003-0073-4429
Nazlı Şensoy(AFYONKARAHISAR HEALTH SCIENCES UNIVERSITY)0000-0001-7449-7513
Pages
—
Publication Date
2026-08-14
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Limitations include the absence of a control group and reliance on self-report at 12 months; randomized controlled trials are warranted.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Tobacco use remains a major global health concern.
📊
Key Findings & Data:This study evaluated the 1-year effectiveness of a standardized biophysical therapy, namely Bioresonance Therapy (BRT), for smoking cessation in a primary care setting.
💡
Conclusion & Impact:Limitations include the absence of a control group and reliance on self-report at 12 months; randomized controlled trials are warranted.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Smoking cessation · nicotine dependence · bioresonance therapy

Abstract

Aim: Tobacco use remains a major global health concern. Despite pharmacological advances, many smokers seek non-invasive interventions due to side-effect concerns. This study evaluated the 1-year effectiveness of a standardized biophysical therapy, namely Bioresonance Therapy (BRT), for smoking cessation in a primary care setting. Material and Methods: In this prospective longitudinal study, 50 adult participants (mean age 44.3 ± 10.4) underwent a standardized BRT protocol. Nicotine dependence was assessed using the Fagerström Test for Nicotine Dependence (FTND). Smoking status was verified via exhaled carbon monoxide (CO) at baseline, 1 month, and 3 months. Continuous abstinence at 12 months was defined as self-reported non-smoking. Factors associated with early relapse, including withdrawal symptoms, were evaluated. Results: The continuous abstinence rate at the 12-month follow-up was 28.0% (n=14). Early relapse within the first month was significantly associated with depressive mood (p=0.012) and sleep disturbances (p=0.008). Baseline FTND scores were not significantly associated with cessation outcomes (p=0.358). No serious adverse events were reported. Conclusion: BRT may represent a potentially useful and feasible non-pharmacological option for smoking cessation in primary care settings. Neuropsychiatric withdrawal symptoms were significantly associated with early relapse, suggesting that additional psychological support may be beneficial for patients experiencing mood or sleep-related difficulties during the cessation process. Limitations include the absence of a control group and reliance on self-report at 12 months; randomized controlled trials are warranted.

🔖

Cite This Article

Dur, G., Şensoy, N. (2026). One-Year Outcomes of Bioresonance Therapy for Smoking Cessation: A Prospective Primary Care Study. International Journal of Traditional and Complementary Medicine Research, Volume: 7 Issue: 2. https://doi.org/10.53811/ijtcmr.1929955

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2025: warning about the dangers of tobacco: executive summary [Internet]. Geneva: World Health Organization; 2025 [cited 2026 Feb 03]. Available from: https://iris.who.int/handle/10665/382309
  2. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885-1906. doi:10.1016/s0140-6736(17)30819-x.
  3. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5.
  4. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507-20. doi:10.1016/S0140-6736(16)30272-0.
  5. Sood A, Ebbert JO, Sood R, Stevens SR. Complementary treatments for tobacco cessation: a survey. Nicotine Tob Res. 2006;8(6):767-71. doi:10.1080/14622200601004109.
  6. Morell F. MORA-Therapie: patienteneigene und farblichtschwingungen - konzept und praxis. Heidelberg: Haug; 1987.
  7. Galle M. Bioresonance therapy with children suffering from allergies: an overview of clinical reports. European Journal of Integrative Medicine. 2009;1(4):234-5. doi:10.1016/j.eujim.2009.08.023.
  8. Herrmann E, Galle M. Retrospective surgery study of the therapeutic effectiveness of MORA bioresonance therapy with conventional therapy resistant patients suffering from allergies, pain and infection diseases. European Journal of Integrative Medicine. 2011;3(3):e237-44. doi:10.1016/j.eujim.2011.05.051.
  9. Foletti A, Baron P, Sclauzero E, Bucci G, Rinaudo A, Rocco R. Assessment of biophysical therapy in the management of pain in current medical practice compared with ibuprofen and placebo: a pilot study. J Biol Regul Homeost Agents. 2014;28(3):471-9.
  10. Nienhaus J, Galle M. [Placebo-controlled study of the effects of a standardized MORA bioresonance therapy on functional gastrointestinal complaints]. Forsch Komplementmed. 2006;13(1):28-34. German. doi:10.1159/000090134.
  11. Foletti A, Grimaldi S, Lisi A, Ledda M, Liboff AR. Bioelectromagnetic medicine: the role of resonance signaling. Electromagn Biol Med. 2013;32(4):484-99. doi:10.3109/15368378.2012.743908.
  12. Galle M. Biophotonen und MORA-Bioresonanz–eine theoretische Annäherung. Erfahrungsheilkunde. 2005;54(5):293-300. doi:10.1055/s-2005-862538.
  13. Podchernyaeva RJ, Lopatina OA, Mikhailova GR, Baklanova OV, Danlibaeva GA, Gushina EA. Effect of exogenous frequency exposure on human cells. Bull Exp Biol Med. 2008;146(1):148-52. doi:10.1007/s10517-008-0224-1.
  14. Isik E. Evidence for efficacy and effectiveness of the MORA bioresonance method in smoking cessation. Poster session presented at: 4th European Congress for Integrative Medicine; 2011 Oct 7-8; Berlin, Germany.
  15. Karadağ M, Karadağ S, Ediz B, Işık E. Nikotin bağımlılığının sigara bırakmadaki etkisi. Yeni Tıp Dergisi. 2011;29(1):27-31.
  16. Pihtili A, Galle M, Cuhadaroglu C, Kilicaslan Z, Issever H, Erkan F, et al. Evidence for the efficacy of a bioresonance method in smoking cessation: a pilot study. Forsch Komplementmed. 2014;21(4):239-45. doi:10.1159/000365742.
  17. Marakoglu K, Yildirim DI, Urun Unal B. Bioresonance therapy for smoking cessation. Istanbul Med J. 2024;25(2):99-104. doi:10.4274/imj.galenos.2024.84555.
  18. Schöni MH, Nikolaizik WH, Schöni-Affolter F. Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol. 1997;112(3):238-46. doi:10.1159/000237460.
  19. Ernst E. Bioresonance, a study of pseudo-scientific language. Forsch Komplementmed. 2004;11(3):171-3. doi:10.1159/000079446.
  20. Uysal MA, Kadakal F, Karşidağ C, Bayram NG, Uysal O, Yilmaz V. Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis. Tuberk Toraks. 2004;52(2):115-21.
  21. Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med. 2006;166(15):1571-7. doi:10.1001/archinte.166.15.1571.
  22. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56-63. doi:10.1001/jama.296.1.56.
  23. White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2014;2014(1):CD000009. doi:10.1002/14651858.CD000009.pub4.
  24. Barnes J, McRobbie H, Dong CY, Walker N, Hartmann-Boyce J. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2019;6(6):CD001008. doi:10.1002/14651858.CD001008.pub3.
  25. Sahebihagh MH, Hosseinzadeh M, Mirghafourvand M, Sarbakhsh P, Nemati H. Challenges of smoking cessation in users of non-invasive stimulation technologies in Iran: a parallel convergent mixed-methods study. BMJ Open. 2024;14(12):e091253. doi:10.1136/bmjopen-2024-091253.